Thermo Fisher Scientific Inc.

Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026: Market to Surge to $21.46 Billion by 2030 as Thermo Fisher Scientific, Merck KGaA, Lonza and Samsung Biologics Accelerate Automation

Boost ROI with scalable viral-vector platforms, automated single-use processing, digital quality control, and expanded CDMO capacity through partnerships and acquisitions.Dublin, Oct. 01, 2026 (GLOBE NEWSWIRE) -- "Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global cell and gene therapy biomanufacturing market is experiencing rapid expansion as advanced therapies move from research and clinical development toward comm

Yahoo Finance · 01/10/2026 · lire l'article ↗

Biomarkers Market Forecasts Growth from $67.95B (2026) to $112.10B by 2031, Profiling Roche, Abbott, Thermo Fisher & Qiagen

The global biomarkers market is projected to grow from USD 67.95 billion in 2026 to USD 112.10 billion by 2031, registering a 10.5% CAGR. Growth is driven by precision medicine, companion diagnostics, AI, bioinformatics, digital pathology and multi-omics technologies. Predictive biomarkers led the efficacy segment in 2025, while immunoassays held the largest technology share. Asia Pacific is forecast to be the fastest-growing region. Key players include Roche, Abbott, Thermo Fisher Scientific, Q

Yahoo Finance · 01/10/2026 · lire l'article ↗

Radiation Detection, Monitoring & Safety Market Forecasts Growth from $3.80B (2026) to $5.68B by 2031, Profiling Fortive, Thermo Fisher & Mirion Technologies

The global radiation detection, monitoring & safety market is projected to grow from USD 3.80 billion in 2026 to USD 5.68 billion by 2031, at an 8.4% CAGR. Growth is driven by expanding medical imaging and radiotherapy, nuclear energy investments, regulatory requirements, and security concerns. Detection and monitoring products and radiation detectors lead the market, while Asia Pacific is set for significant growth. Key players include Fortive, Thermo Fisher Scientific, Mirion Technologies, Fuj

Yahoo Finance · 01/10/2026 · lire l'article ↗

Recombinant Proteins Market - Global Strategic Business Report: Sales Hit to $5.8 Billion by 2030 - Benchmark Thermo Fisher Scientific, Merck KGaA, Amgen, Bio-Techne and GenScript Biotech Amid Tariff Disruption

Demand for biologics, targeted therapies and personalized medicine is rising, while AI-led protein design and scalable bioprocessing unlock new opportunities.Dublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Recombinant Proteins Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global recombinant proteins market was valued at US$3.3 billion in 2024 and is projected to reach US$5.8 billion by 2030, expanding at a compound annual growth rate of 10.2%. Ma

Yahoo Finance · 30/09/2026 · lire l'article ↗

Fetal Bovine Serum Market Outlook 2026-2035 - Featuring Profiles of Leading Companies Thermo Fisher Scientific, Merck KGaA, and Cytiva

Fetal Bovine Serum Market Gains Momentum as Stem Cell Research, Vaccine Innovation and Advanced Therapies Drive Demand for High-Quality, Ethically Sourced ProductsDublin, Sept. 30, 2026 (GLOBE NEWSWIRE) -- "Fetal Bovine Serum Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. The global fetal bovine serum market was valued at USD 1.1 billion in 2025 and is projected to reach USD 2.3 billion by 2035, expanding

Yahoo Finance · 30/09/2026 · lire l'article ↗

Thermo Fisher Scientific (TMO) Stock Seems Reasonable Following Its 47% Run

Thermo Fisher Scientific has been a strong performer over the past year, and that kind of run naturally raises a pointed question for anyone looking at the stock today. Is the current share price aligned with the cash flows the business is expected to generate, or has sentiment moved ahead of the underlying economics? The stock has returned 47.4% over the past year, which puts real pressure on the question of whether the current valuation still lines up with the cash being produced and...

Yahoo Finance · 29/09/2026 · lire l'article ↗